• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • FoxWayne, Aerami Therapeutics SPAC Deal Said Worth $195 Million firstwordpharma
    August 16, 2021
    According to people familiar with the matter, Aerami Therapeutics is holding talks with blank-check firm FoxWayne Enterprises about a potential merger that could value the combined company at about $195 million, reported Bloomberg.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service